Helping Cambodian people living with HIV quit smoking using mobile technology
Ending Tobacco Use through Interactive Tailored Messaging for Cambodian People Living with HIV/AIDS (EndIT)
This study is testing a helpful smartphone app to support Cambodians living with HIV/AIDS who want to quit smoking, making it easier and more affordable for them to get the care they need.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | H. Lee Moffitt Cancer Ctr & Res Inst NIH-funded |
| Lab location | 1 site (Tampa, United States) |
| Project ID | NIH-10912473 on NIH RePORTER |
What this research studies
This research aims to reduce tobacco use among Cambodian individuals living with HIV/AIDS by implementing a mobile health intervention. The approach includes a randomized controlled trial that combines pharmacological and behavioral treatments delivered through an interactive smartphone application. This method is designed to be cost-effective and scalable, addressing the high smoking rates in this vulnerable population. By utilizing technology, the study seeks to provide tailored support for tobacco cessation, ultimately improving health outcomes for participants.
Who could benefit from this research
Good fit: Ideal candidates for this research are Cambodian adults aged 21 and older who are living with HIV and currently smoke cigarettes.
Not a fit: Patients who do not smoke or are not living with HIV may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the health and quality of life for Cambodian people living with HIV by helping them quit smoking.
How similar studies have performed: Previous research has shown success in using mobile health interventions for smoking cessation in various populations, although this specific approach in Cambodia is relatively novel.
Where this research is happening
Tampa, United States
- H. Lee Moffitt Cancer Ctr & Res Inst — Tampa, United States (Active)
Researchers
- Principal investigator: Vidrine, Damon J. — H. Lee Moffitt Cancer Ctr & Res Inst
- Study coordinator: Vidrine, Damon J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.